{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:27:20Z","timestamp":1793978840115,"version":"4.8.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB0830301"],"award-info":[{"award-number":["XDB0830301"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB1260302"],"award-info":[{"award-number":["XDB1260302"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304301"],"award-info":[{"award-number":["82304301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["[2024]015"],"award-info":[{"award-number":["[2024]015"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021B1515420002"],"award-info":[{"award-number":["2021B1515420002"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24JS2830200"],"award-info":[{"award-number":["24JS2830200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["YDZX20233100004032"],"award-info":[{"award-number":["YDZX20233100004032"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119217","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:02:22Z","timestamp":1786633342000},"page":"119217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Recent advances in TEAD modulators: A medicinal chemistry perspective"],"prefix":"10.1016","volume":"319","author":[{"given":"Naixin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dounan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8920-9355","authenticated-orcid":false,"given":"Huan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119217_bib1","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ncb1050","article-title":"Hippo promotes proliferation arrest and apoptosis in the Salvador\/Warts pathway","volume":"5","author":"Udan","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119217_bib2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/ncb1051","article-title":"The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila","volume":"5","author":"Pantalacci","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119217_bib3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0092-8674(03)00557-9","article-title":"The Drosophila mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis","volume":"114","author":"Harvey","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119217_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0092-8674(03)00549-X","article-title":"Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts","volume":"114","author":"Wu","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119217_bib5","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","article-title":"Elucidation of a universal size-control mechanism in drosophila and mammals","volume":"130","author":"Dong","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119217_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2005.06.007","article-title":"The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating yorkie, the Drosophila homolog of YAP","volume":"122","author":"Huang","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119217_bib7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","article-title":"Hippo pathway in organ size control, tissue homeostasis, and cancer","volume":"163","author":"Yu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119217_bib8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.molmed.2015.01.003","article-title":"Disease implications of the Hippo\/YAP pathway","volume":"21","author":"Plouffe","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2026.119217_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12967-024-05027-8","article-title":"Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer","volume":"22","author":"Schiavoni","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.119217_bib10","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3892\/ijo.2015.2877","article-title":"YAP\/TAZ for cancer therapy: opportunities and challenges (Review)","volume":"46","author":"Guo","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2026.119217_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41420-022-01020-6","article-title":"Hippo signaling pathway and respiratory diseases","volume":"8","author":"Tang","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejmech.2026.119217_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.340","article-title":"YAP\/TAZ: molecular pathway and disease therapy","volume":"4","author":"Wei","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.ejmech.2026.119217_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11010-020-03866-9","article-title":"YAP\/TAZ affects the development of pulmonary fibrosis by regulating multiple signaling pathways","volume":"475","author":"Zhu","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2026.119217_bib14","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160135","article-title":"TAZ promotes cell growth and inhibits Celastrol-induced cell apoptosis","volume":"36","author":"Wang","year":"2016","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejmech.2026.119217_bib15","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1021\/acs.jpcb.3c07073","article-title":"Allosteric modulation of the YAP\/TAZ-TEAD interaction by palmitoylation and small-molecule inhibitors","volume":"128","author":"Mills","year":"2024","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2026.119217_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114847","article-title":"Advances of targeting the YAP\/TAZ-TEAD complex in the hippo pathway for the treatment of cancers","volume":"244","author":"Luo","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","article-title":"The Hippo signalling pathway and its implications in human health and diseases","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2026.119217_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13046-023-02704-2","article-title":"New insights into the ambivalent role of YAP\/TAZ in human cancers","volume":"42","author":"Luo","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119217_bib19","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1038\/s44319-025-00515-4","article-title":"Hippo pathway controls biopterin metabolism to shield adjacent cells from ferroptosis in lung cancer","volume":"26","author":"Li","year":"2025","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ejmech.2026.119217_bib20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/cas.70299","article-title":"Hippo pathway drives durable non\u2010cell\u2010autonomous ferroptosis resistance in lung cancer","volume":"117","author":"Saleh","year":"2025","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejmech.2026.119217_bib21","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1038\/s12276-025-01551-9","article-title":"The multifaceted role of YAP in the tumor microenvironment and its therapeutic implications in cancer","volume":"57","author":"Kim","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2026.119217_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41580-018-0086-y","article-title":"Hippo\u2013YAP\/TAZ signalling in organ regeneration and regenerative medicine","volume":"20","author":"Moya","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119217_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113926","article-title":"The Hippo signaling pathway in development and regeneration","volume":"43","author":"Zhong","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2026.119217_bib24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12943-018-0882-1","article-title":"The role of YAP\/TAZ activity in cancer metabolic reprogramming","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2026.119217_bib25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12272-021-01322-w","article-title":"The essential role of TAZ in normal tissue homeostasis","volume":"44","author":"Jeong","year":"2021","journal-title":"Arch. Pharmacal. Res."},{"key":"10.1016\/j.ejmech.2026.119217_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/genes7090055","article-title":"Targeting the hippo signaling pathway for tissue regeneration and cancer therapy","volume":"7","author":"Juan","year":"2016","journal-title":"Genes"},{"key":"10.1016\/j.ejmech.2026.119217_bib27","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/cells10061416","article-title":"The Hippo pathway: a master regulatory network important in cancer","volume":"10","author":"Liu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.119217_bib28","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s41588-022-01119-7","article-title":"YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis","volume":"54","author":"Wu","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2026.119217_bib29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/ijms17010138","article-title":"The TEAD family and its oncogenic role in promoting tumorigenesis","volume":"17","author":"Zhou","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119217_bib30","article-title":"TEAD transcription factors are required for normal primary myoblast differentiation in vitro and muscle regeneration in vivo","volume":"13","author":"Barsh","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ejmech.2026.119217_bib31","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1038\/onc.2017.24","article-title":"DNA-binding mechanism of the Hippo pathway transcription factor TEAD4","volume":"36","author":"Shi","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2026.119217_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1101\/gad.1865810","article-title":"Structural insights into the YAP and TEAD complex","volume":"24","author":"Li","year":"2010","journal-title":"Gene Dev."},{"key":"10.1016\/j.ejmech.2026.119217_bib33","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/ncb3216","article-title":"Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth","volume":"17","author":"Zanconato","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119217_bib34","doi-asserted-by":"crossref","first-page":"18957","DOI":"10.1021\/acs.jmedchem.4c01393","article-title":"Pan-transcriptional enhanced associated domain palmitoylation pocket covalent inhibitor","volume":"67","author":"Kim","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118330","article-title":"Targeting YAP\/TAZ\u2013TEAD and their protein-protein interaction for precision cancer therapy","volume":"302","author":"Chen","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1021\/acs.jmedchem.2c01189","article-title":"Small-molecule cyanamide Pan-TEAD\u00b7YAP1 covalent antagonists","volume":"66","author":"Bum-Erdene","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib37","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1039\/D3CB00044C","article-title":"A covalent inhibitor of the YAP\u2013TEAD transcriptional complex identified by high-throughput screening","volume":"4","author":"Nutsch","year":"2023","journal-title":"RSC Chem. Biol."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119217_bib38","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1021\/acsmedchemlett.3c00386","article-title":"Development of HC-258, a Covalent Acrylamide TEAD Inhibitor That Reduces Gene Expression and Cell Migration","volume":"14","author":"Fnaiche","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119217_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-22-0681","article-title":"A novel irreversible TEAD inhibitor, SWTX-143, blocks Hippo pathway transcriptional output and cause","volume":"23","author":"Hillen","year":"2024","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2026.119217_bib40","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2174\/0113892002351556250123105344","article-title":"In vitro and in vivo drug metabolism analysis of BPI-460372 - A covalent TEAD1\/3\/4 inhibitor","volume":"25","author":"Liu","year":"2024","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2026.119217_bib41","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1021\/acschembio.5c00283","article-title":"Small-molecule covalent stabilization and inhibition of the TEAD YAP1 transcription factor in cancer cells","volume":"20","author":"Yeh","year":"2025","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119217_bib42","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1021\/acs.jmedchem.6c00104","article-title":"Integrated strategic design and in situ click chemistry approach to rapid discovery of novel potent covalent TEAD inhibitors","volume":"69","author":"Miao","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib43","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1021\/acs.jmedchem.8b01402","article-title":"Antiproliferative and antimigratory effects of a novel YAP\u2013TEAD interaction inhibitor identified using in silico molecular docking","volume":"62","author":"Smith","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.stem.2020.03.002","article-title":"Lats1\/2 sustain intestinal stem cells and Wnt activation through TEAD-dependent and independent transcription","volume":"26","author":"Li","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejmech.2026.119217_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1021823","article-title":"Structure-based discovery of a novel small-molecule inhibitor of TEAD palmitoylation with anticancer activity","volume":"12","author":"Gridnev","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2026.119217_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129488","article-title":"Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings","volume":"95","author":"Fnaiche","year":"2023","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119217_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113835","article-title":"Discovery of a cryptic site at the interface 2 of TEAD \u2013 towards a new family of YAP\/TAZ-TEAD inhibitors","volume":"226","author":"Sturbaut","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib48","article-title":"Discovery of a new class of reversible TEA domain transcription factor inhibitors with a novel binding mode","volume":"11","author":"Liu","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2026.119217_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105707","article-title":"Identification of small-molecule YAP-TEAD inhibitors by high-throughput docking for the treatment of colorectal cancer","volume":"122","author":"Li","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib50","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1002\/cmdc.202100432","article-title":"Development of LM98, a small\u2010molecule TEAD inhibitor derived from flufenamic acid","volume":"16","author":"M\u00e9lin","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119217_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79992-x","article-title":"Discovering the inhibition of YAP\/TEAD Hippo signaling pathway via new pyrazolone derivatives: synthesis, molecular docking and biological investigations","volume":"14","author":"Noser","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119217_bib52","doi-asserted-by":"crossref","first-page":"24603","DOI":"10.1021\/acs.jmedchem.5c02602","article-title":"Phenotypic hit identification and optimization of novel Pan-TEAD and subtype-selective inhibitors","volume":"68","author":"Heinrich","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib53","article-title":"The first class of small molecules potently disrupting the YAP\u2010TEAD interaction by direct competition","volume":"17","author":"Furet","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119217_bib54","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1021\/acs.jctc.3c01318","article-title":"SWISH-X, an expanded approach to detect cryptic pockets in proteins and at protein\u2013protein interfaces","volume":"20","author":"Borsatto","year":"2024","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2026.119217_bib55","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the roots of cancer","volume":"29","author":"Zanconato","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2026.119217_bib56","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","article-title":"Targeted protein degradation: mechanisms, strategies and application","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2026.119217_bib57","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1021\/acsmedchemlett.4c00029","article-title":"Design, synthesis, and bioevaluation of transcriptional enhanced assocciated domain (TEAD) PROTAC degraders","volume":"15","author":"Li","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119217_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.692574","article-title":"PROTAC: an effective targeted protein degradation strategy for cancer therapy","volume":"12","author":"Qi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119217_bib59","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41580-023-00644-5","article-title":"Control of stem cell renewal and fate by YAP and TAZ","volume":"24","author":"Driskill","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119217_bib60","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41568-023-00579-1","article-title":"Insights into recent findings and clinical application of YAP and TAZ in cancer","volume":"23","author":"Franklin","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.119217_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114684","article-title":"A chemical perspective on the modulation of TEAD transcriptional activities: recent progress, challenges, and opportunities","volume":"243","author":"Lou","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118056","article-title":"Identification of pyrazolo-piperidinone derivatives targeting YAP-TEAD interface 3 as anticancer agents through integrated virtual screening and mass spectrometry proteomics","volume":"300","author":"Scalvini","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib63","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1016\/j.apsb.2021.04.015","article-title":"Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3","volume":"11","author":"Lu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119217_bib64","article-title":"Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling","volume":"11","author":"Lu","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2026.119217_bib65","doi-asserted-by":"crossref","first-page":"16270","DOI":"10.1021\/acs.jmedchem.4c00925","article-title":"Development of novel indole-based covalent inhibitors of TEAD as potential antiliver cancer agents","volume":"67","author":"Zhou","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-64682-7","article-title":"Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma models","volume":"16","author":"Ott","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119217_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118299","article-title":"Discovery of repurposed ethacrynic acid and its derivatives as novel TEAD inhibitors","volume":"302","author":"Chen","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-74722-5","article-title":"Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer model","author":"Hagenbeek","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119217_bib69","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1158\/1535-7163.MCT-20-0717","article-title":"Small molecule inhibitors of TEAD auto-palmitoylation selectively inhibit proliferation and tumor growth of NF2-deficient mesothelioma","volume":"20","author":"Tang","year":"2021","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2026.119217_bib70","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s43018-023-00577-0","article-title":"An allosteric pan-TEAD inhibitor blocks oncogenic YAP\/TAZ signaling and overcomes KRAS G12C inhibitor resistance","volume":"4","author":"Hagenbeek","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ejmech.2026.119217_bib71","doi-asserted-by":"crossref","first-page":"9206","DOI":"10.1021\/acs.jmedchem.2c00403","article-title":"Optimization of TEAD P-Site binding fragment hit into in vivo active lead MSC-4106","volume":"65","author":"Heinrich","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108911","article-title":"Discovery and characterization of sulfonamide derivatives as transcriptional enhanced associate domain (TEAD) inhibitors: a novel approach for targeting hepatocellular carcinoma","volume":"165","author":"Lu","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118886","article-title":"Discovery and optimization of novel TEAD inhibitors for in vivo investigation against hepatocellular carcinoma","volume":"313","author":"Xu","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.119112","article-title":"Repurposing-inspired discovery of novel sagitta-shaped covalent TEAD inhibitors from NSAID diflunisal","volume":"317","author":"Chen","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib75","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1021\/acs.jmedchem.5c03009","article-title":"Discovery of clinical candidate IAG933, a potent YAP-TEAD PPI disrupter","volume":"69","author":"V\u00f6gtle","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib76","author":"Fisher"},{"key":"10.1016\/j.ejmech.2026.119217_bib77","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1021\/acs.jmedchem.4c02884","article-title":"Selective degradation of TEADs by a PROTAC molecule exhibited robust anticancer efficacy in vitro and in vivo","volume":"68","author":"Lu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202503277","article-title":"Discovery of a potent and selective TEAD degrader with durable degradation activity","volume":"12","author":"Cao","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejmech.2026.119217_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadva.2021.100008","article-title":"Narciclasine is a novel YAP inhibitor that disturbs interaction between YAP and TEAD4","volume":"1","author":"Kawamoto","year":"2021","journal-title":"BBA Adv."},{"key":"10.1016\/j.ejmech.2026.119217_bib80","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.3390\/cancers13164246","article-title":"Hot spot analysis of YAP-TEAD protein-protein interaction using the fragment molecular orbital method and its application for inhibitor discovery","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2026.119217_bib81","article-title":"Aurintricarboxylic acid is a canonical disruptor of the TAZ-TEAD transcriptional complex","volume":"17","author":"Zhang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119217_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300051","article-title":"Optimization of a class of dihydrobenzofurane analogs toward orally efficacious YAP\u2010TEAD protein\u2010protein interaction inhibitors","volume":"18","author":"Sellner","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119217_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106274","article-title":"Discovery of dioxo-benzo[b]thiophene derivatives as potent YAP-TEAD interaction inhibitors for treating breast cancer","volume":"131","author":"Son","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib84","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1038\/s41467-022-34559-0","article-title":"Pharmacological blockade of TEAD\u2013YAP reveals its therapeutic limitation in cancer cells","volume":"13","author":"Sun","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119217_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2026.102881","article-title":"The YAP-TEAD4 inhibitor M511-0965 suppresses triple-negative breast cancer progression by downregulating TGFB2","volume":"71","author":"Cheng","year":"2026","journal-title":"Transl. Oncol"},{"key":"10.1016\/j.ejmech.2026.119217_bib86","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s42004-025-01871-x","article-title":"Expanding the toolbox to develop IAP-based degraders of TEAD transcription factors","volume":"9","author":"Gupta","year":"2026","journal-title":"Commun. Chem"},{"key":"10.1016\/j.ejmech.2026.119217_bib87","article-title":"Targeted degradation of specific TEAD paralogs by small molecule degraders","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2026.119217_bib88","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1158\/1538-7445.AM2023-1646","article-title":"Abstract 1646: IK-930, a paralog-selective TEAD inhibitor for treating YAP\/TAZ-TEAD dependent cancers","volume":"83","author":"Young","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119217_bib89","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3390\/cells13070564","article-title":"Hippo signaling at the hallmarks of cancer and drug resistance","volume":"13","author":"Kumar","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.119217_bib90","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12935-023-02940-8","article-title":"The genetic landscape and possible therapeutics of neurofibromatosis type 2","volume":"23","author":"Ghalavand","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejmech.2026.119217_bib91","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1158\/1538-7445.AM2024-1656","article-title":"Abstract 1656: ISM6331, a novel and potent pan-TEAD inhibitor, exhibits strong anti-tumor activity in preclinical models of Hippo pathway-dysregulated cancers","volume":"84","author":"Li","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119217_bib92","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1158\/1538-7445.AM2025-4728","article-title":"Abstract 4728: the selective Yap\/Tead inhibitor TY-1054 re-sensitizes acquired resistance to multiple tyrosine kinase-based targeted therapies","volume":"85","author":"Dong","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119217_bib93","doi-asserted-by":"crossref","first-page":"LB428","DOI":"10.1158\/1538-7445.AM2024-LB428","article-title":"Abstract LB428: discovery of KY-001:A direct inhibitor of TEAD-YAP protein-protein interaction for the treatment of advanced solid tumors with abnormal hippo signaling pathway","volume":"84","author":"Zhao","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119217_bib94","doi-asserted-by":"crossref","first-page":"8647","DOI":"10.1021\/acs.jmedchem.6c01021","article-title":"Illuminating clinical TEAD inhibitors through structural biology","volume":"69","author":"Kang","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib95","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1158\/1538-7445.AM2023-1671","article-title":"Abstract 1671: discovery of ETS-003, a potent and selective YAP\/TAZ-TEAD PPI inhibitor with broad anti-tumor activity in Hippo-YAP aberrant cancers","volume":"83","author":"Lu","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119217_bib96","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1158\/1538-7445.AM2023-4976","article-title":"Abstract 4976: preclinical characterization of BGI-9004, a covalent TEAD inhibitor with exceptional anti-cancer activity and combination potential","volume":"83","author":"Guo","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119217_bib97","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noaf201.1464","article-title":"EXTH-132. Evaluation of TEAD inhibitor, VT3989, treatment in aggressive meningioma","volume":"27","author":"Desai","year":"2025","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejmech.2026.119217_bib98","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1158\/1535-7163.MCT-24-0308","article-title":"TEAD-independent cell growth of hippo-inactive mesothelioma cells: unveiling resistance to TEAD inhibitor K-975 through MYC signaling activation","volume":"24","author":"Akao","year":"2025","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2026.119217_bib99","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s42003-024-06190-w","article-title":"Genome-wide CRISPR screens identify the YAP\/TEAD axis as a driver of persister cells in EGFR mutant lung cancer","volume":"7","author":"Pfeifer","year":"2024","journal-title":"Commun. Biol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119217_bib100","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s43018-024-00754-9","article-title":"Direct and selective pharmacological disruption of the YAP\u2013TEAD interface by IAG933 inhibits Hippo-dependent and RAS\u2013MAPK-altered cancers","volume":"5","author":"Chapeau","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ejmech.2026.119217_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108425","article-title":"Structure-based optimization of TEAD inhibitors: exploring a novel subpocket near Glu347 for the treatment of NF2-mutant cancer","volume":"159","author":"Kim","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib102","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1021\/acs.jmedchem.5c02997","article-title":"Discovery and in vivo evaluation of Aryl Ether YAP1\/TEAD inhibitors for the treatment of Hippo-Driven malignancies","volume":"69","author":"Vara","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119217_bib103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-4939-3673-1_5","article-title":"AlphaScreen-Based assays: ultra-high-throughput screening for small-molecule inhibitors of challenging enzymes and protein-protein interactions","volume":"1439","author":"Yasgar","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.119217_bib104","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1021\/acs.chemrestox.6b00248","article-title":"Advances in predictive toxicology for discovery safety through high content screening","volume":"29","author":"Persson","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2026.119217_bib105","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202503241","article-title":"Pipeline to evaluate YAP-TEAD inhibitors indicates TEAD inhibition represses NF2-mutant mesothelioma","volume":"8","author":"Cunningham","year":"2025","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.ejmech.2026.119217_bib106","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.3390\/ijms25105358","article-title":"Leveraging the fragment molecular orbital and MM-GBSA methods in virtual screening for the discovery of novel non-covalent inhibitors targeting the TEAD lipid binding pocket","volume":"25","author":"Kim","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119217_bib107","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1039\/b901969n","article-title":"In situ click chemistry: probing the binding landscapes of biological molecules","volume":"39","author":"Mamidyala","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2026.119217_bib108","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2425984122","article-title":"TEAD-targeting small molecules induce a cofactor switch to regulate the Hippo pathway","volume":"122","author":"Guarnaccia","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2026.119217_bib109","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1038\/s41591-025-04029-3","article-title":"YAP\/TEAD inhibitor VT3989 in solid tumors: a phase 1\/2 trial","volume":"31","author":"Yap","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119217_bib110","article-title":"Unleashing the power of DNA-encoded libraries for challenging targets in drug discovery","volume":"4","author":"Du","year":"2026","journal-title":"PHSA"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:00:32Z","timestamp":1793977232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426006628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":110,"alternative-id":["S0223523426006628"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119217","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in TEAD modulators: A medicinal chemistry perspective","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119217"}}